###begin article-title 0
TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events
###end article-title 0
###begin p 1
###xml 35 57 35 57 <email xmlns:xlink="http://www.w3.org/1999/xlink">kcavassa@med.umich.edu</email>
###xml 79 101 79 101 <email xmlns:xlink="http://www.w3.org/1999/xlink">slkunkel@med.umich.edu</email>
CORRESPONDENCE Karen A. Cavassani: kcavassa@med.umich.edu OR Steven L. Kunkel: slkunkel@med.umich.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 706 709 702 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 702 709 698 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 818 821 814 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 814 821 810 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
Ligands from dying cells are a source of Toll-like receptor (TLR) activating agents. Although TLR3 is known to respond to RNA from necrotic cells, the relative importance of this response in vivo during acute inflammatory processes has not been fully explored. We observed the involvement of TLR3 activation during experimental polymicrobial septic peritonitis and ischemic gut injury in the absence of an exogenous viral stimulus. In TLR3-deficient mice, increased chemokine/cytokine levels and neutrophil recruitment characterized the initial inflammatory responses in both injury models. However, the levels of inflammatory chemokines and tumor necrosis factor alpha quickly returned to baseline in tlr3-/- mice, and these mice were protected from the lethal effects of sustained inflammation. Macrophages from tlr3-/- mice responded normally to other TLR ligands but did not respond to RNA from necrotic neutrophils. Importantly, an immunoneutralizing antibody directed against TLR3 attenuated the generation of inflammatory chemokines evoked by byproducts from necrotic neutrophils cultured with wild-type macrophages. In vivo, anti-TLR3 antibody attenuated the tissue injury associated with gut ischemia and significantly decreased sepsis-induced mortality. Collectively, these data show that TLR3 is a regulator of the amplification of immune response and serves an endogenous sensor of necrosis, independent of viral activation.
###end p 3
###begin p 4
Abbreviations used: AST, aspartate aminotransferase; CLP, cecal ligation and puncture; HMGB1, high mobility group box 1; LDH, lactic acid dehydrogenase; MIP-2, macrophage inflammatory protein 2; MPO, myeloperoxidase; PAMP, pathogen-associated molecular pattern; PI, propidium iodide; PMN, polymorphonuclear neutrophil; poly(I:C), polyriboinosinic-polyribocytidylic acid; TLR, Toll-like receptor.
###end p 4
###begin p 5
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 867 868 867 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 891 892 891 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 1235 1237 1235 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
The innate immune system provides a first line of defense via the detection and elimination of pathogens. Pathogen-associated molecular patterns (PAMPs) are recognized by Toll-like receptors (TLRs), which activate inflammatory pathways leading to de novo cytokine and chemokine generation. When innate immunity is not appropriately regulated or the pathogen not contained, local and systemic inflammation can lead to severe pathophysiologic consequences (1, 2). Factors released from stressed or damaged tissues serve as "danger signals," and these might provide the innate immune system with activation ligands (3). "Endogenous ligands" are potent activators of the innate immune response (4-7), and the TLRs appear to be the target of these factors. In this regard, TLR3 activation aggravates and/or potentiates preexisting inflammation associated with the kidney (8), rheumatic synovium (9), and gastrointestinal tract (10, 11). In addition, TLR3 ligand amplifies the systemic hyperinflammatory response observed during sepsis (12). Although TLR3 recognizes viral double-stranded RNA, recent studies have suggested that RNA released from either damaged tissue or contained within endocytosed cells might serve as a ligand for TLR3 (13). Whether TLR3 functions in this manner during inflammatory responses in vivo is presently unknown.
###end p 5
###begin p 6
###xml 383 386 383 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 379 386 379 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
This study addressed the hypothesis that TLR3 regulates the inflammatory response during polymicrobial septic peritonitis and ischemic bowel injury. In the absence of an exogenous viral pathogen, TLR3 activation was important for the initiation and the amplification of inflammation via recognition of cellular by-products from necrotic, but not apoptotic, cells. Interestingly, tlr3-/- mice were protected from the lethal effects of total cecal ligation alone and cecal ligation and puncture (CLP)-induced experimental sepsis. In addition, antibody-mediated immunoneutralization of TLR3 activation suppressed the tissue injury mediated by necrosis of the gut and sepsis-induced mortality in WT mice. Collectively, these data demonstrate that TLR3 regulates amplification events during inflammation mediated by nonviral mechanisms.
###end p 6
###begin title 7
RESULTS
###end title 7
###begin title 8
Up-regulation of TLR3 in macrophages and neutrophils after sepsis
###end title 8
###begin p 9
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 918 926 918 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 1046 1049 1046 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1042 1049 1042 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1056 1064 1056 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1211 1212 1211 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1220 1235 1220 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, C and D</xref>
###xml 1357 1358 1357 1358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1398 1406 1398 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 1547 1555 1547 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
###xml 1125 1129 <span type="species:ncbi:10090">mice</span>
###xml 1275 1279 <span type="species:ncbi:10090">mice</span>
###xml 1541 1545 <span type="species:ncbi:10090">mice</span>
PAMPs activate TLR-induced signaling pathways, leading to the induction of innate immune responses. A mixed pathological picture is associated with CLP, which includes the elicitation of various leukocyte populations, vascular permeability changes, and significant necrosis of the gut tissue (14). This latter pathology may hold an important key in understanding endogenous signals that amplify the innate response, as growing evidence has suggested that host-derived RNA (9, 13) from necrotic cells serve as major stimuli for TLR3 activation. To assess the expression pattern of TLR3 during the development of CLP sepsis, we initially localized the expression of TLR3. Although peritoneal macrophages and neutrophils recovered from the sham WT mice did not express TLR3, the expression of TLR3, via immunohistochemistry, was detected in these cell populations from mice undergoing experimental sepsis induced by CLP (Fig. 1 A). As a control, no expression of this receptor was detected in thioglycollate-elicited peritoneal macrophages from tlr3-/- mice (Fig. 1 B), confirming the specificity of this antibody. At 24 h, CLP mice showed increased intracellular expression of TLR3 in peritoneal and splenic CD11b+ cells (Fig. 1, C and D, respectively) when compared with sham mice. Surprisingly, CLP also induced the extracellular expression of TLR3 in CD11b+ cells isolated from peritoneal lavage (Fig. 1 E). No statistical differences were observed at the extracellular expression of this molecule in spleen cells from CLP and sham surgery mice (Fig. 1 F).
###end p 9
###begin p 10
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CLP surgery induced local and systemic expression of TLR3.</bold>
###xml 325 328 324 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 321 328 320 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 446 447 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 518 519 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 758 761 754 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 754 761 750 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 838 842 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
CLP surgery induced local and systemic expression of TLR3. (A) Representative immunochemistry analysis of TLR3 expression in peritoneal cells from sham and CLP 6 h after surgery. TLR3 expression is observed in brown. Bars, 20 mum. (B) Immunochemistry analysis of TLR3 expression in thioglycollate-elicited macrophages of tlr3-/- mice. Bar, 20 mum. (C and D) Histograms exhibit TLR3 expression in permeabilized peritoneal (C) and splenic (D) CD11b+ cells. (E and F) Nonpermeabilized peritoneal (E) and splenic (F) CD11b+ cells (gray line, isotype control antibody; shaded, sham mice; black line, CLP mice). Data are means +/- SEM from three independent experiments. (G) Immunoreactive CCL3 and MIP-2 supernatant levels from thioglycollate-elicited WT and tlr3-/- peritoneal neutrophils exposed to poly(I:C). *, P < 0.05 compared with sham mice; section sign, P < 0.05 compared with WT mice.
###end p 10
###begin p 11
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 108 116 108 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 307 315 307 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 G</xref>
###xml 439 442 439 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 435 442 435 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Given that we observed the presence of TLR3+ neutrophils in cytospins of peritoneal cells from septic mice (Fig. 1 A), we further evaluated the effects of polyriboinosinic-polyribocytidylic acid (poly(I:C)) on chemokine generation by purified peritoneal neutrophils (see Materials and methods). As shown in Fig. 1 G, poly(I:C) promoted the release of CCL3 and macrophage inflammatory protein 2 (MIP-2) from WT neutrophils but not from tlr3-/- neutrophils. Thus, peritoneal inflammatory stimuli promoted the expression of functional TLR3 in macrophages and neutrophils.
###end p 11
###begin title 12
The absence of TLR3 enhanced the influx of neutrophils, but suppressed necrosis and apoptosis, during experimental peritonitis
###end title 12
###begin p 13
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 113 119 113 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 196 199 196 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 192 199 192 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 260 268 260 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 405 408 405 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 401 408 401 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 437 445 437 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 623 626 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 619 626 619 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 727 735 727 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 839 842 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 835 842 835 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1161 1164 1161 1164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1157 1164 1157 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1294 1297 1294 1297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1290 1297 1290 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1332 1333 1332 1333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 1336 1337 1336 1337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1384 1385 1383 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 1298 1302 <span type="species:ncbi:10090">mice</span>
###xml 1315 1319 <span type="species:ncbi:10090">mice</span>
The contribution of TLR3 to septic peritonitis in WT and tlr3-/- mice after sham or CLP surgery is summarized in Fig. 2. A significantly greater number of peritoneal cells were present in the tlr3-/- group compared with the WT group at 24 h after CLP surgery (Fig. 2 A). Significantly higher peritoneal levels of myeloperoxidase (MPO; a specific marker of neutrophil recruitment) were also present in tlr3-/- mice compared with WT mice (Fig. 2 B). Moreover, peritoneal washes from septic mice were characterized by considerable necrotic cellular debris and bacterial contamination, whereas similar washings from septic tlr3-/- mice contained greater numbers of neutrophils, little necrotic cellular debris, and fewer bacteria (Fig. 2 C). It is worth noting that although peritoneal neutrophil numbers were significantly greater in the tlr3-/- group compared with the WT group after 24 h following CLP surgery, neutrophil numbers returned to equivalent levels in the peritoneal cavity in the surviving WT and knockout groups at 72 h after CLP (unpublished data). Consistent with the decreased presence of bacteria contamination in peritoneal washes from the tlr3-/- group at 24 h after CLP surgery, we observed that bacteria were not detected in the peritoneal fluid and blood in any of the tlr3-/- mice, whereas WT mice exhibited 104-106 log bacteria/CFU/mul of peritoneal wash and 105 log bacteria/CFU/mul of blood.
###end p 13
###begin p 14
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 120 127 120 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 0 133 0 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Increased peritoneal neutrophil influx and a marked reduction in necrotic peritoneal cells during septic peritonitis in <italic>tlr3<sup>&#8722;/&#8722;</sup></italic> mice.</bold>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 145 152 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 412 415 410 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 408 415 406 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 529 530 526 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 533 534 530 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 548 549 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 552 553 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 612 613 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
Increased peritoneal neutrophil influx and a marked reduction in necrotic peritoneal cells during septic peritonitis in tlr3-/- mice. (A) WT and tlr3-/- peritoneal cells at 24 h after sham and CLP surgeries. (B) MPO levels in peritoneal lavage samples at 24 h after either sham or CLP surgery. Data are means +/- SEM from two separate experiments. (C) Toluidine blue staining of peritoneal cells from WT and tlr3-/- mice at 24 h after CLP surgery. Bars, 50 mum. (D and E) Apoptotic and necrotic cells were identified by annexin V+/PI- and annexin V+/PI+ staining, respectively. The data represent means +/- SEM (n = 5 mice per condition). *, P < 0.05; and **, P < 0.01 compared with C57BL/6 mice after CLP surgery.
###end p 14
###begin p 15
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 278 281 278 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 274 281 274 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 730 733 730 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 726 733 726 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
The increased peritoneal neutrophilia in septic tlr3-/- mice at 24 h after surgery might be explained by an enhanced responsiveness of immune cells from these mice to other bacterial PAMPs, including TLR4 and 9 agonists. Both TLRs were increased in whole spleen from septic tlr3-/- mice relative to identical spleen samples from septic WT mice (Fig. S1 A, available at ). Consistent with this observation, isolated peritoneal neutrophils released significantly greater levels of CXCL10 after exposure to synthetic oligodeoxynucleotide (CpG-ODN) and the chemokine KC after exposure to LPS (Fig. S1 B). Also, the marked absence of bacteria in peritoneal washes from the knockout group might be explained by our observation that tlr3-/- neutrophils exhibited a marked increase in basal reactive oxygen intermediate generation compared with WT neutrophils (unpublished data).
###end p 15
###begin p 16
###xml 100 103 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 241 244 225 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 237 244 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 265 273 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 405 413 389 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
FACS analysis confirmed the marked absence of necrotic cells in the peritoneal cavity of septic tlr3-/- mice. At 24 h, 46 +/- 7% of peritoneal cells from septic mice were necrotic and approximately22 +/- 1% of peritoneal cells in septic tlr3-/- mice were necrotic (Fig. 2 D), and this difference reached statistical significance. Between 4 and 7% of peritoneal cells in both septic groups were apoptotic (Fig. 2 E). Collectively, these findings demonstrate that TLR3 regulates the amplification of acute inflammatory response evoked by a septic peritoneal challenge.
###end p 16
###begin title 17
TLR3 activation contributes to organ injury induced by septic peritonitis and gut ischemia
###end title 17
###begin p 18
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 170 177 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 246 254 246 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 372 375 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 368 375 344 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 476 478 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 688 696 664 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 941 944 917 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 937 944 913 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1236 1239 1212 1215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1232 1239 1208 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
###xml 1226 1230 <span type="species:ncbi:10090">mice</span>
###xml 1240 1244 <span type="species:ncbi:10090">mice</span>
To evaluate the contribution of TLR3 activation on the mortality induced by septic peritonitis, we monitored survival rates in tlr3-/- and WT mice for 8 d after CLP. The tlr3-/- animals were significantly protected from sepsis-induced lethality (Fig. 3 A). The data show that approximately80% of WT mice were dead at 4 d after CLP surgery, whereas approximately80% of tlr3-/- mice were alive at day 8 after surgery. Mortality in the CLP model is caused by multiorgan failure (14), including ischemic injury to the bowel. In addition to the septic injury, we examined the role of TLR3 in ischemic injury to the gastrointestinal tract induced by complete ligation of the cecum. As shown in Fig. 3 B, complete ligation of the cecum without punctures for 24 h in WT mice caused severe necrotic injury to this portion of the bowel, characterized by the near total loss of tissue architecture and integrity. In contrast, the same procedure in tlr3-/- mice was associated with markedly less destruction to the architecture of the cecum and the cell infiltrate, and the contents of the cecum were still apparent in this organ, suggesting that reduced intralumen of its contents had leaked into the peritoneal cavity. Compared with WT mice, tlr3-/- mice showed significantly reduced levels of alanine aminotransferase, aspartate aminotransferase (AST), bilirubin, and lactic acid dehydrogenase (LDH) after 6 and 24 h following CLP surgery, and at 24 h after total cecal ligation (Fig. S2, available at ). Collectively, these findings are consistent with the concept that TLR3 activation contributes to the magnitude of the inflammatory response evoked by both septic and necrotic processes in the damaged gastrointestinal tract.
###end p 18
###begin p 19
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>tlr3<sup>&#8722;/&#8722;</sup></italic> mice are resistant to lethality after CLP surgery and exhibit less tissue damage after gut ischemia.</bold>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 170 177 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 397 398 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
tlr3-/- mice are resistant to lethality after CLP surgery and exhibit less tissue damage after gut ischemia. (A) Septic peritonitis was induced by CLP in WT (n = 20) and tlr3-/- (n = 17) mice. Mortality was monitored every 24 h for 8 d. ***, P < 0.0001 compared with the WT group. (B) Representative Masson's trichrome staining of cecum at 24 h after gut ischemia induced by total cecal ligation (n = 6). Bars, 100 mum.
###end p 19
###begin title 20
TLR3 amplified local and systemic inflammatory responses
###end title 20
###begin p 21
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 273 276 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 269 276 266 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 311 319 308 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 353 361 350 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 375 383 372 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 408 411 405 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 404 411 401 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 484 492 477 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 501 509 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 523 531 516 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 F</xref>
###xml 709 712 702 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 705 712 698 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 748 759 741 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, A&#8211;F</xref>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
We next assessed whether the generation of inflammatory cytokines and chemokines differed between WT and tlr3-/- mice during septic inflammatory responses in the peritoneal cavity. At 6 h after CLP surgery, peritoneal levels of IFN-beta were significant reduced in the tlr3-/- group compared with the WT group (Fig. 4 A). The peritoneal levels of CCL5 (Fig. 4 B) and CXCL10 (Fig. 4 C) were higher in the tlr3-/- group compared with the WT group at this time, but levels of TNF-alpha (Fig. 4 D), CCL3 (Fig. 4 E), and MIP-2 (Fig. 4 F) were similar in the two groups of mice at 6 h after CLP. At 24 h after CLP surgery, all peritoneal levels of the cytokines and chemokines were significantly reduced in the tlr3-/- CLP group versus the WT CLP group (Fig. 4, A-F).
###end p 21
###begin p 22
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Acute but not sustained peritoneal inflammation in <italic>tlr3<sup>&#8722;/&#8722;</sup></italic> mice after CLP or gut ischemia.</bold>
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 233 236 233 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 229 236 229 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Acute but not sustained peritoneal inflammation in tlr3-/- mice after CLP or gut ischemia. (A-F) At 6 and 24 h after CLP surgery, WT and tlr3-/- peritoneal cytokine and chemokine concentrations were measured by ELISA. (G) WT and tlr3-/- peritoneal cytokine and chemokine concentrations were measured by ELISA. The data represent means +/- SEM obtained from three independent experiments for CLP and two independent experiments for gut ischemia. *, P < 0.05 compared with WT groups. nd, not detected.
###end p 22
###begin p 23
###xml 317 320 313 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 313 320 309 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 354 362 350 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 G</xref>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
Ischemia of the cecum was also associated with significant increases in inflammatory chemokines and cytokines, including CCL3, CCL5, and TNF-alpha. Analysis of peritoneal lavage from cecal-ligated mice revealed that all three of these inflammatory mediators were significantly attenuated at 24 h after surgery in tlr3-/- mice when compared with WT mice (Fig. 4 G).
###end p 23
###begin title 24
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Multiorgan injury caused by septic inflammatory responses was significantly attenuated in tlr3-/- mice
###end title 24
###begin p 25
###xml 357 360 357 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 353 360 353 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 401 412 401 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, A&#8211;C</xref>
###xml 488 491 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 484 491 484 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
Our data demonstrate that the absence of TLR3 had a dramatic regulatory effect on the magnitude and duration of the inflammatory response in the peritoneal cavity; therefore, we next assessed whether this modulatory effect extended to other organs. Most notably, whole lung and spleen levels of CXCL10, CCL3, and CCL2 were significantly lower in septic tlr3-/- mice when compared with septic WT mice (Fig. 5, A-C). Collectively, these data indicated that the inflammatory response in tlr3-/- mice after a septic inflammatory stimulus was restrained and regulated in a manner that markedly decreased the degree of inflammation in other organs in these mice.
###end p 25
###begin p 26
###xml 0 100 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TLR3 amplified systemic inflammatory responses and secondary tissue injury after septic peritonitis.</bold>
###xml 271 272 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
TLR3 amplified systemic inflammatory responses and secondary tissue injury after septic peritonitis. (A-C) At 24 h after sham and CLP surgeries, chemokines were measured in lung and spleen homogenates using ELISA. Data are means +/- SEM from two independent experiments (n = 4-5 mice per experiment). *, P < 0.05; and **, P < 0.01 compared with WT groups.
###end p 26
###begin title 27
Absence of signaling through TLR3 blocked the activation of macrophages by necrotic neutrophils
###end title 27
###begin p 28
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 311 318 311 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 534 535 534 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 539 540 539 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 555 563 555 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 618 626 618 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 B</xref>
###xml 636 644 636 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 C</xref>
###xml 653 661 653 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 D</xref>
###xml 668 676 668 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 E</xref>
###xml 691 699 691 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 F</xref>
###xml 814 817 814 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 810 817 810 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 881 892 881 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, B&#8211;F</xref>
###xml 1051 1062 1051 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, B&#8211;F</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
We addressed the possibility that the lack of amplification of the inflammatory response in tlr3-/- mice after injury was caused by their inability to respond to byproducts from necrotic cells. Accordingly, we examined the role of TLR3 in the generation of inflammatory chemokines by isolated peritoneal WT and tlr3-/- macrophages after their co-culture with necrotic polymorphonuclear neutrophils (PMNs) or apoptotic splenocytes. In cultures of WT macrophages, the addition of necrotic neutrophils (97% of cells were propidium iodide+ (PI+), as shown in Fig. 6 A) for 24 h significantly increased the levels of CCL5 (Fig. 6 B), MIP-2 (Fig. 6 C), CCL3 (Fig. 6 D), KC (Fig. 6 E), and CXCL10 (Fig. 6 F) above control (medium alone) levels. In marked contrast, the addition of necrotic neutrophils to cultures of tlr3-/- macrophages did not induce the expression of these chemokines (Fig. 6, B-F). However, chemokine responses evoked by the addition of apoptotic spleen cells (depicted) or neutrophils (not depicted) did not appear to be TLR3 dependent (Fig. 6, B-F).
###end p 28
###begin p 29
###xml 0 124 0 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TLR3 was required for chemokine generation by peritoneal macrophages after co-culture with necrotic but not apoptotic cells.</bold>
###xml 206 207 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 282 285 282 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 583 586 581 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 579 586 577 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 693 696 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 689 696 687 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
TLR3 was required for chemokine generation by peritoneal macrophages after co-culture with necrotic but not apoptotic cells. (A) The necrotic cells were identified by analyzing the side scatter (SSC) and PI+ staining. (B-F) Chemokine concentrations in the supernatants of WT or tlr3-/- peritoneal macrophages co-cultured with necrotic neutrophils, apoptotic splenocytes, poly(I:C), CpG-ODN, Pam3Cys, or LPS and quantified using ELISA and/or Bio-Plex. The data are means +/- SEM from three to four combined experiments. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 compared with tlr3-/- mice. (G and H) KC (G) and MIP-2 (H) protein levels in 96-well tissue culture plates containing WT or tlr3-/- macrophages and one of untreated, RNase-, or Benzonase-treated necrotic PMNs. **, P < 0.01 when necrotic PMNs were compared with medium; #, P < 0.05 when enzyme-treated necrotic PMNs were compared with nontreated necrotic PMNs.
###end p 29
###begin p 30
###xml 88 91 88 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 84 91 84 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 354 357 354 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 350 357 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 517 525 517 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 D</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 696 699 696 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 692 699 692 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
Further analysis of cytokine and chemokine generation by cultured peritoneal WT and tlr3-/- macrophages confirmed that the latter group of macrophages was significantly less responsive to poly(I:C) activation, but responses to this synthetic ligand were still present in TLR3-deficient cells, as has been shown previously (15). We also observed that tlr3-/- macrophages generated significantly greater levels of CCL3 after TLR9 activation via hypomethylated DNA (i.e., CpG-ODN) for 24 h compared with WT macrophages (Fig. 6 D). However, activators of macrophages derived from necrotic/apoptotic cells, namely vimentin (16) and high mobility group box 1 (HMGB1) protein (17), activated WT and tlr3-/- macrophages to the same extent (Fig. S3, available at ).
###end p 30
###begin p 31
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 532 548 520 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 (G and H)</xref>
###xml 633 641 621 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 G</xref>
###xml 653 661 641 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 H</xref>
###xml 808 811 796 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 804 811 792 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
Because RNA released from damaged tissue might serve as a ligand for TLR3 (13), we next explored the possibility that RNA from necrotic PMNs was the signal from these cells that drove chemokine synthesis in peritoneal macrophages. To further explore this possibility, we added RNase or Benzonase to necrotic PMN samples, and RNA quantification showed that both of these enzyme treatments reduced the concentration of nucleic material within these samples by approximately50% or more compared with untreated PMN samples. As shown in Fig. 6 (G and H), the presence of RNase or Benzonase did not evoke the release of the chemokines KC (Fig. 6 G) or MIP-2 (Fig. 6 H) to the same extent as untreated necrotic PMN samples. Further, we again observed that necrotic PMNs failed to evoke KC or MIP-2 synthesis by tlr3-/- macrophages, and the addition of RNase- or Benzonase-treated PMN samples to these cells did not change chemokine levels in culture. Collectively, these data demonstrate that nucleic acid products from injured and/or necrotic cells contribute to the inflammatory response evoked in macrophages via TLR3 ligation.
###end p 31
###begin title 32
Antibody-mediated immunoneutralization of TLR3 inhibited WT macrophage chemokine synthetic responses to the presence of necrotic neutrophils
###end title 32
###begin p 33
###xml 125 133 125 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 288 291 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 284 291 272 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr7<sup>&#8722;/&#8722;</sup></italic>
###xml 322 325 310 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 318 325 306 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 348 356 336 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 498 501 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 494 501 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr7<sup>&#8722;/&#8722;</sup></italic>
###xml 654 657 630 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 650 657 626 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 837 845 813 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
Using Western blot analysis, we examined the specificity of our polyclonal antibody directed against mouse TLR3. As shown in Fig. 7 A, this antibody detected recombinant TLR3 protein (a band at approximately140 kD), as well as in poly(I:C)-stimulated macrophages from WT (lane 1) and tlr7-/- (lane 2) mice, but not in tlr3-/- (lane 3) macrophages (Fig. 7 A). As would be expected given the polyclonal nature of this antibody, other bands were detected in the macrophage samples from the WT and tlr7-/- mice, but it appeared that these additional bands (approximately60-80 kD) were specific for TLR3 because they were not detected by this antibody in tlr3-/- macrophages. Next, a functional analysis of TLR3 signaling was performed in purified WT peritoneal macrophage cultures exposed to necrotic neutrophils or stimulated by poly(I:C) (Fig. 7 B and Fig. S4 [available at ], respectively). After exposure to poly(I:C) alone or poly(I:C) and control IgG for 24 h, CCL2, CCL3, CCL5, MIP-2, KC, and TNF-alpha were prominently expressed in supernatants from these cultures. In contrast, the presence of anti-TLR3 antibody significantly reduced the chemokine generation by poly(I:C)-activated peritoneal macrophages (Fig. S4 A). However, the anti-TLR3 antibody did not have any effect on CCL2, CCL3, CCL5, and TNF-alpha production induced by LPS, CpG-DNA, and PamCys3 (Fig. S4 B).
###end p 33
###begin p 34
###xml 0 115 0 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TLR3 was required for chemokine generation by WT peritoneal macrophages after co-culture with necrotic neutrophils.</bold>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr7<sup>&#8722;/&#8722;</sup></italic>
###xml 317 320 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 313 320 313 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 150 156 <span type="species:ncbi:9986">rabbit</span>
TLR3 was required for chemokine generation by WT peritoneal macrophages after co-culture with necrotic neutrophils. (A) The specificity of polyclonal rabbit anti-TLR3 was determined by Western blot analysis of TLR3 expression in the following samples: lane 1, WT macrophages; lane 2, tlr7-/- macrophages; lane 3, tlr3-/- macrophages; and lane 4, recombinant TLR3. The black line indicates that intervening lanes have been spliced out. (B-E) Chemokine concentrations in the supernatants of WT peritoneal macrophages co-cultured with necrotic neutrophils with IgG or anti-TLR3 polyclonal antibody were quantified using Bio-Plex. The data are means +/- SEM of triplicate wells and are representative of three independent experiments. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 compared with IgG group.
###end p 34
###begin p 35
###xml 215 219 <span type="species:ncbi:10090">mice</span>
We also examined the relative effect of endosomal acidification via chloroquine treatment on the neutralizing ability of this anti-TLR3 antibody. In cultures of peritoneal macrophages from thioglycollate-challenged mice stimulated with poly(I:C) in the presence of IgG or anti-TLR3 antibody, the presence of 10 muM chloroquine did not markedly impair the neutralizing activity of anti-TLR3 antibody when compared with IgG treatment (Fig. S5 A, available at ). These data suggested that activity of this antibody might not be restricted to TLR3 blockade in the endosome. In addition, the presence of chloroquine did not alter the effects of anti-TLR3 antibody on the synthesis of CCL5, CCL3, KC, and MIP-2 (Fig. S5 A). As a control, the production of chemokines by LPS-activated macrophages, which depends of TLR4, is neither affected by chloroquine or anti-TLR3 blockade (Fig. S5 B). These data confirmed that this TLR3-directed antibody specifically alters the activating effects of a known TLR3 ligand.
###end p 35
###begin p 36
###xml 284 292 281 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 301 309 298 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 318 326 315 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 D</xref>
###xml 337 345 334 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 E</xref>
###xml 687 698 681 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, B&#8211;E</xref>
In additional in vitro studies, WT necrotic neutrophils were co-cultured with WT peritoneal macrophages in a 1:1 ratio with either control IgG, anti-IFN-beta antibody, or anti-TLR3 antibody. The presence of necrotic neutrophils and IgG significantly increased the synthesis of MIP-2 (Fig. 7 B), CCL5 (Fig. 7 C), CCL3 (Fig. 7 D), and KC (Fig. 7 E) by WT macrophage. The inclusion of an antibody directed against IFN-beta in this co-culture system resulted in chemokine generation that was similar to that observed in co-cultures with IgG (unpublished data). However, the addition of anti-TLR3 antibody to this cell co-culture system significantly decreased levels of all four chemokines (Fig. 7, B-E). Thus, these data showed that the activation of peritoneal macrophages by necrotic neutrophils was dependent on TLR3.
###end p 36
###begin title 37
Antibody-mediated immunoneutralization of TLR3 attenuated the tissue damage mediated by gut ischemia and significantly reduced sepsis-induced mortality
###end title 37
###begin p 38
###xml 594 602 594 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 A</xref>
###xml 805 813 805 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 B</xref>
###xml 956 964 956 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 C</xref>
###xml 1442 1450 1442 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 D</xref>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
###xml 1063 1067 <span type="species:ncbi:10090">mice</span>
###xml 1406 1410 <span type="species:ncbi:10090">mice</span>
Given that the genetic absence of TLR3 provided a dramatic protective and modulatory effect during septic and ischemic inflammatory responses in the peritoneal cavity, we next assessed whether this effect could be achieved through antibody-mediated immunoneutralization of this TLR. We therefore assessed the effect of this neutralizing anti-TLR3 antibody in WT mice subjected to total cecal ligation and CLP. IgG administration before total cecal ligation provided no protective effect, as indicated by severe tissue necrosis and marked disruption of the normal gastrointestinal architecture (Fig. 8 A, inset) observed at 24 h after surgery. In marked contrast, anti-TLR3 antibody administration preserved the histological appearance of cecal tissue analyzed in WT mice that received anti-TLR3 antibody (Fig. 8 B). The protective effect of neutralizing TLR3 receptors in this necrosis model was reflected by decreased levels of AST and LDH serum enzymes (Fig. 8 C). To examine the role of TLR3 during septic responses in WT mice, anti-TLR3 antibody was given to mice according to the following posttreatment regimens: (a) at 3 h before CLP surgery only; (b) 3 and 24 h after CLP surgery; and (c) at 6 and 24 h after CLP surgery. Although anti-TLR3 treatment regimens a and b did not affect the overall survival after CLP, anti-TLR3 treatment regimen c had a marked protective effect on the survival of WT mice after the induction of sepsis (Fig. 8 D). Collectively, these data demonstrate that the beneficial effects of TLR3 gene deficiency can be achieved via an anti-TLR3 antibody-directed approach.
###end p 38
###begin p 39
###xml 0 132 0 132 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Anti-TLR3 antibody markedly reduced cecal damage induced by gut ischemia and enhanced survival after the induction of severe sepsis.</bold>
###xml 501 502 500 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 771 772 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 811 812 808 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 356 361 <span type="species:ncbi:10090">mouse</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
Anti-TLR3 antibody markedly reduced cecal damage induced by gut ischemia and enhanced survival after the induction of severe sepsis. (A and B) Representative histological sections from WT mice that received either IgG (A) or anti-TLR3 (B) antibody during gut ischemia. The inset in A is a representative histological cross section of cecum from a naive WT mouse. Bars, 100 mum. (C) At 24 h after surgery, serum from WT mice subjected to cecal ischemia and either IgG or anti-TLR3 antibody treatments (n = 4 mice per group) were analyzed for AST and LDH. The data are means +/- SEM. *, P < 0.05 compared with the IgG group. (D) WT mice received 3 mg of anti-TLR3 antibody or isotype control at 6 and 24 h after CLP surgery, and the survival rates were monitored for 54 h (n = 7 for the anti-TLR3 antibody group; n = 8 for the IgG group).
###end p 39
###begin title 40
DISCUSSION
###end title 40
###begin p 41
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 827 828 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1042 1045 1042 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1038 1045 1038 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1343 1346 1343 1346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1339 1346 1339 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1507 1510 1507 1510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1503 1510 1503 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 859 863 <span type="species:ncbi:10090">mice</span>
###xml 1046 1050 <span type="species:ncbi:10090">mice</span>
###xml 1347 1351 <span type="species:ncbi:10090">mice</span>
###xml 1511 1515 <span type="species:ncbi:10090">mice</span>
###xml 1537 1541 <span type="species:ncbi:10090">mice</span>
###xml 1696 1701 <span type="species:ncbi:10090">mouse</span>
Initiation and amplification events in the inflammatory response are complex, and the relative role of the TLR system in these events adds to this complexity. The recognition of PAMPs by TLRs has garnered much of the research attention in the elucidation of innate immunity in the context of pathogen exposure. However, growing evidence suggests that TLRs exert a prominent role in the response to endogenous signals provided by the host during injury events (7). In the present study, we examined the relative importance of TLR3, a TLR initially characterized for its responses to double-stranded RNA (15) but more recently for its response to endogenous nucleic acids from necrotic cells (9, 13). We observed that during septic peritonitis, intracellular as well as extracellular TLR3 expression was markedly induced in CD11b+ cells. The absence of TLR3 in mice was protective in the context of both CLP surgery and gut ischemia. Two key features were noted in these injury models. First, the initiation of the inflammatory response in tlr3-/- mice was enhanced compared with appropriate WT controls. Specifically, we observed that neutrophil influx into the peritoneal cavity was significantly increased, and this influx was associated with increased CXC chemokine levels. Second, the inflammatory response was quickly contained within tlr3-/- mice, in large part because of the absence of an amplifying effect of byproducts from necrotic but not apoptotic cells. Importantly, this latter feature in tlr3-/- mice was replicated in WT mice via the use of an immunoneutralizing antibody directed against TLR3. Thus, the absence or the modulation of TLR3 activity has major beneficial effects in mouse models of peritonitis characterized by infection and tissue necrosis.
###end p 41
###begin p 42
###xml 26 28 26 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 30 32 30 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 770 772 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 1289 1292 1289 1292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1285 1292 1285 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1032 1037 <span type="species:ncbi:10090">mouse</span>
###xml 1112 1117 <span type="species:ncbi:9606">human</span>
###xml 1180 1185 <span type="species:ncbi:10090">mouse</span>
TLR3 is expressed in DCs (18, 19), astrocytes (20), Schwann cells (21), macrophages (22), glomerular mesangial cells (8, 23), T cells (24), epithelial cells (25, 26), fibroblasts (27), and hepatocytes (11). Although TLR3 is present mainly within the endosomic compartment of these cell types, epithelial cells appear to uniquely express this TLR on their cell surface as well (26); however, we observed, like others (28), that during inflammation macrophages express this receptor on the surface. These results were confirmed in studies in which the presence of chloroquine did not alter the inhibitory effect of the anti-TLR3 antibody during poly(I:C)-induced chemokine synthesis by inflamed macrophages. Viral infection drives TLR3 expression in epithelial cells (29, 30), but TLR3 expression can be driven during chronic inflammation in the absence of virus or viral byproducts (31). Herein, we observed that TLR3 protein was expressed in macrophages and neutrophils after sepsis. The observation that TLR3 was induced in septic mouse neutrophils was novel because this TLR has only been reported in isolated human neutrophils (32). The presence of functional TLR3 in inflamed mouse neutrophils was confirmed by the addition of poly(I:C), which induced CCL3 and MIP-2 in WT but not tlr3-/- neutrophils. Thus, TLR3 expression was induced in macrophages and neutrophils in the absence of a viral stimulus.
###end p 42
###begin p 43
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 755 758 755 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 751 758 751 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 1137 1140 1137 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1133 1140 1133 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1267 1270 1267 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1263 1270 1263 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
###xml 1141 1145 <span type="species:ncbi:10090">mice</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1271 1275 <span type="species:ncbi:10090">mice</span>
Severe sepsis, a lethal syndrome after infection or injury, is the third leading cause of mortality in the United States (2), and it is characterized by multiorgan damage because of the fact that the excessive inflammation directed toward the infectious pathogen precipitates major tissue damage. Several initiation signals direct the migration of mononuclear cells and neutrophils during sepsis, but this response must be tightly regulated to avoid tissue injury (33). In the present study, the absence of TLR3 was associated with an increase in neutrophil recruitment into the peritoneal cavity in mice undergoing CLP and into the wall of the ischemic cecum at the 24-h time point. One explanation for the increased initial inflammatory response in tlr3-/- mice stems from our observation that neutrophils and macrophages generated significantly greater amounts of CXCL10 and KC, two potent neutrophil chemoattractants (34), after exposure to hypomethylated DNA, a ligand for TLR9. Consistent with this explanation, it was observed that significantly greater quantities of CXCL10 were detected in the peritoneal cavities of septic tlr3-/- mice compared with WT mice. Also, at 6 h after CLP both TLR4 and TLR9 were markedly increased in innate immune cells from tlr3-/- mice. The activation of these receptors might account for the increased neutrophil recruitment and effective bacterial killing initially observed in the knockout.
###end p 43
###begin p 44
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 252 255 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 248 255 248 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 929 932 922 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 925 932 918 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1024 1027 1017 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1020 1027 1013 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1242 1245 1228 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1238 1245 1224 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1413 1416 1399 1402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1409 1416 1395 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1462 1465 1448 1451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1458 1465 1444 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 933 937 <span type="species:ncbi:10090">mice</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
###xml 1246 1250 <span type="species:ncbi:10090">mice</span>
###xml 1326 1330 <span type="species:ncbi:10090">mice</span>
###xml 1417 1421 <span type="species:ncbi:10090">mice</span>
###xml 1466 1470 <span type="species:ncbi:10090">mice</span>
The amplified inflammatory response during peritonitis is characterized by the exuberant presence of cytokines and chemokines, and these mediators contribute directly and indirectly to tissue and organ destruction (33, 35, 36). Previous studies in tlr3-/- mice have noted that these mice exhibit markedly altered cytokine and chemokine generation in response to poly(I:C) (15) or a viral infection (11, 37-40). The intestinal tract appears to be highly susceptible to the damaging effects of double-stranded RNA, leading to a breakdown in the homeostasis in this organ system (10). Recently, Doughty et al. (12) reported that the activation of a TLR3 pathway with poly(I:C) in mice before septic peritonitis caused by CLP surgery significantly augmented the inflammatory response in this model, in part because of the up-regulation of IFN-alpha/beta. The results from the present study expand these previous findings in that tlr3-/- mice were markedly resistant to the lethal effects of CLP. This decreased mortality in tlr3-/- mice was also associated with significantly lower levels of many proinflammatory cytokines (including IFN-beta and TNF-alpha) and chemokines at 24 h after CLP surgery. Similarly, during total cecal ischemia in tlr3-/- mice, cytokine and chemokine levels were significantly reduced compared with WT mice, suggesting that the amplification of the inflammatory cascade was blunted in tlr3-/- mice. Thus, the inflammatory response in tlr3-/- mice was regulated in a manner consistent with tissue preservation.
###end p 44
###begin p 45
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 328 331 328 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 324 331 324 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 624 627 624 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 620 627 620 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 990 992 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 1027 1028 1027 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 1255 1257 1255 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
The factors contributing to poorly regulated inflammatory responses such as those observed in sepsis and gut ischemia are not well understood, but tissue necrosis might provide a major "danger" signal that inappropriately amplifies inflammation (3). In the present study, significantly fewer necrotic cells were observed in tlr3-/- mice after sepsis. Further, the coincubation of necrotic neutrophils with WT macrophages promoted the release of many chemokines, most notably CXCL10. This effect was restricted to co-cultures of necrotic neutrophils and WT macrophages, because the co-culture of necrotic neutrophils and tlr3-/- macrophages failed to show similar elevations in proinflammatory cytokines and chemokines. Tissue necrosis leads to the release of several cellular components, including heat shock proteins, HMGB1, and nucleic acids. Heat shock proteins and HMGB1 have been shown or suggested to be agonists for TLR2 and TLR4 (41), whereas mRNA is an endogenous ligand for TLR3 (13). More recently, Brentano et al. (9) showed that RNA released from necrotic synovial cells activated fibroblasts in the arthritic joint in a TLR3-dependent manner. Also, necrotic neuronal cells were found to induce inflammatory Schwann cell activation via TLR3 (21). Although vimentin and HMGB1 are intracellular proteins, which are released during cell apoptosis and necrosis, respectively, neither factor appeared to activate peritoneal macrophages in a TLR3-dependent manner. However, the treatment of necrotic neutrophils with endonuclease or RNase significantly inhibited the ability of these cells to induce inflammatory chemokine secretion by WT "inflamed" macrophages. These findings lend credence to our hypothesis that RNA released from necrotic cells activates TLR3, leading to the amplification of the inflammatory response. Thus, TLR3 amplifies the inflammatory process in the peritoneal cavity, and its role in this process appears to be related to the detection of RNA from necrotic cells.
###end p 45
###begin p 46
###xml 217 220 217 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 213 220 213 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr7<sup>&#8722;/&#8722;</sup></italic>
###xml 292 295 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 288 295 288 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 814 817 810 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 810 817 806 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 1596 1598 1592 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 1612 1614 1608 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
###xml 853 857 <span type="species:ncbi:10090">mice</span>
The development and characterization of an antibody directed against TLR3 allowed for the examination of TLR3 blockade in in vitro and in vivo experiments. We observed that this antibody recognized TLR3 in WT and tlr7-/- peritoneal macrophages but failed to detect any protein product in tlr3-/- macrophages. Moreover, the anti-TLR3 antibody significantly attenuated the cytokine- and chemokine-inducing effects of poly(I:C) and necrotic neutrophils by WT macrophages. Studies with chloroquine-treated "inflamed" peritoneal macrophages raised the possibility that this antibody worked via the blockade of TLR3 at the cell surface, but we cannot exclude the possibility that the neutralizing TLR3 antibody was internalized by macrophages via Fc gamma receptor-mediated endocytosis. Importantly, the findings in tlr3-/- mice were duplicated in vivo in WT mice using a neutralizing antibody directed against TLR3. Specifically, tissue necrosis was significantly reduced after the administration of this antibody before the induction of gut ischemia. Interestingly, the administration of anti-TLR3 antibody at 6 and 24 h after CLP surgery, but not at earlier times after CLP surgery, had a significant protective effect, which is likely caused by the time interval needed to induce cell necrosis in this model. These findings are consistent with the role of TLR3 in the amplification of the inflammatory response after sepsis. Thus, TLR3 can now be included with the select group of molecules known to contribute to the amplification of the septic response. Other members on this list include HMGB1 (17) and TREM-1 (42).
###end p 46
###begin p 47
###xml 16 19 16 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
In summary, tlr3-/- mice showed regulated peritoneal and systemic inflammation after tissue injury in the absence of a viral challenge. Thus, the use of antibody directed against TLR3 might serve as a therapeutic clinical option in the treatment of necrosis-induced inflammatory events.
###end p 47
###begin title 48
MATERIALS AND METHODS
###end title 48
###begin title 49
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 49
###begin p 50
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 113 120 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 298 301 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 294 301 294 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 358 361 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr7<sup>&#8722;/&#8722;</sup></italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
Specific pathogen-free, male C57BL/6 (WT) mice (aged 6-8 wk; Taconic) were housed at the University of Michigan. tlr3-/- mice, backcrossed 10 generations onto a C57BL/6 background, were originally provided by R. Flavell (Yale University School of Medicine, New Haven, CT); a breeding colony of tlr3-/- mice was established at the University of Michigan. tlr7-/- mice were provided by G. Nunez (University of Michigan Medical School, Ann Arbor, MI). The Animal Use Committee at the University of Michigan approved all in vivo protocols used in this study. Age- and sex-matched mice were used in these studies.
###end p 50
###begin title 51
Models.
###end title 51
###begin p 52
Thioglycollate-induced sterile peritonitis was induced by the i.p. injection of 2% thioglycollate (Sigma-Aldrich).
###end p 52
###begin p 53
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 714 717 708 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 710 717 704 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 348 353 <span type="species:ncbi:10090">mouse</span>
For polymicrobial sepsis, WT and tlr3-/- mice were subjected to sham or CLP surgery, as previously described in detail (43). CLP and sham mice were anesthetized, bled, and killed at 6 and 24 h after surgery; lung, spleen, and peritoneal cells were collected. Peritoneal lavage fluids were harvested, and these fluids and peripheral blood from each mouse were serially diluted and plated on brain heart infusion agar and incubated overnight at 37degreesC, and bacteria colonies were counted. Cell-free peritoneal fluids were used for chemokine, cytokine, and MPO detection by ELISA. Single-cell peritoneal suspensions were stained with Toluidine blue (Thermo Fisher Scientific). In separate experiments, WT and tlr3-/- CLP groups were monitored for survival over 8 d.
###end p 53
###begin p 54
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Total ischemic bowel injury was induced by the complete ligation of the cecum in WT and tlr3-/- mice. Cecums were exteriorized as described, but not punctured with a needle, and were returned to the peritoneal cavity, and the incision was closed with a surgical staple. At 24 h, the peritoneal cavity was flushed with saline, blood was drawn for clinical chemistry, and the cecum was collected for histology.
###end p 54
###begin title 55
###xml 14 20 <span type="species:ncbi:9986">rabbit</span>
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Generation of rabbit anti-mouse polyclonal TLR3-specific antibody.
###end title 55
###begin p 56
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 49 56 <span type="species:ncbi:9986">rabbits</span>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
###xml 255 262 <span type="species:ncbi:9986">rabbits</span>
TLR3 antibody was generated in New Zealand white rabbits with recombinant mouse TLR3 (carrier free; R&D Systems), as previously described in detail (44). This antibody was tittered by ELISA against TLR3 coated onto 96-well plates. Serum from nonimmunized rabbits was used for a control treatment group.
###end p 56
###begin title 57
Flow cytometry.
###end title 57
###begin p 58
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 149 154 <span type="species:ncbi:10090">mouse</span>
###xml 373 379 <span type="species:ncbi:9986">rabbit</span>
###xml 385 390 <span type="species:ncbi:10090">mouse</span>
###xml 412 418 <span type="species:ncbi:9986">rabbit</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
Splenic and peritoneal cells from WT mice were analyzed for TLR3 at 24 h after surgery. For intracellular staining, Fc binding was blocked with anti-mouse CD16/32 antibody (eBioscience), and the cells were incubated with label PE-conjugated anti-CD11b. Cells were fixed, permeabilized with Cytofix/Cytoperm (BD Biosciences), incubated with 2 mug of biotinylated polyclonal rabbit anti-mouse TLR3 or biotinylated rabbit IgG, and stained with streptavidin-allophycocyanin. For extracellular staining of TLR3, the cells were not permeabilized. All stained cells were analyzed using a Cytomics FC 500 (Beckman Coulter). Peritoneal cells from both groups of mice were also stained with Alexa Fluor 488-labeled Annexin V and 1 mug/ml PI (both from Invitrogen) for 15 min. Flow cytometry analysis was performed immediately thereafter.
###end p 58
###begin title 59
Immunocytochemistry.
###end title 59
###begin p 60
###xml 136 142 <span type="species:ncbi:9986">rabbit</span>
###xml 260 271 <span type="species:ncbi:3704">horseradish</span>
Cytospin preparations of peritoneal cells were fixed in a 4% equal mixture of paraformaldehyde and sucrose, and incubated with purified rabbit polyclonal anti-TLR3 antibody or control IgG. The presence of TLR3 was revealed using a cell and tissue staining and horseradish peroxidase-DAB kit (R&D Systems).
###end p 60
###begin title 61
Western blot analysis.
###end title 61
###begin p 62
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr7<sup>&#8722;/&#8722;</sup></italic>
###xml 144 145 144 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 222 227 <span type="species:ncbi:10090">mouse</span>
###xml 397 403 <span type="species:ncbi:9986">rabbit</span>
###xml 409 414 <span type="species:ncbi:10090">mouse</span>
###xml 513 519 <span type="species:ncbi:9986">rabbit</span>
###xml 813 819 <span type="species:ncbi:9986">rabbit</span>
Macrophages from WT, tlr3-/-, and tlr7-/- mice stimulated with poly(I:C) for 24 h were lysed, kept on ice for 20 min, and centrifuged at 15,000 g for 15 min. Equal amounts of cell lysates (18 mug) and 10 ng of recombinant mouse TLR3 (R&D Systems) were fractionated by SDS-PAGE (NuPage; Invitrogen), followed by transfer onto nitrocellulose (Invitrogen). After overnight incubation with polyclonal rabbit anti-mouse TLR3 antibody (dilution = 1:1,000), membranes were counterstained with peroxidase-conjugated anti-rabbit IgG and visualized with enhanced chemiluminescence detection reagents (ECL; GE Healthcare). Membranes were stripped in Restore Buffer (Thermo Fisher Scientific) at 50degreesC for 45 min, blocked with 5% nonfat milk, and reprobed with anti-GAPDH (Abcam), followed by peroxidase-conjugated anti-rabbit IgG. The images were analyzed using ImageJ software (version 1.37; National Institutes of Health).
###end p 62
###begin title 63
Proteomic analysis of cytokines, chemokines, and MPO.
###end title 63
###begin p 64
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
Immunoreactive levels of chemokines and cytokines were measured in cultured cell supernatants, peritoneal lavage, lung, and spleen homogenates using a modified double-ligand ELISA assay, as previously described in detail (44, 45), or a cytokine assay (Bio-Plex; Bio-Rad Laboratories). Before each ELISA, snap-frozen lung and spleen samples were thawed on ice and homogenized in a solution containing 2 mg of protease inhibitor (Complete; Boehringer Mannheim) per milliliter of normal saline. Cell-free supernatants from the lung and spleen homogenates were analyzed. MPO activity in peritoneal lavage samples was determined by ELISA (Hycult biotechnology). All cytokine and chemokine levels were normalized to the total protein concentration from tissues and peritoneal lavage, as determined by the Bradford method (Bio-Rad Laboratories).
###end p 64
###begin title 65
In vitro macrophage and neutrophil activation.
###end title 65
###begin p 66
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 327 343 324 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 889 893 883 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 898 901 892 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neg</sup>
###xml 1022 1024 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 1183 1184 1170 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1280 1281 1266 1267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 327 343 <span type="species:ncbi:562">Escherichia coli</span>
Macrophages and neutrophils were obtained from thioglycollate-challenged WT and tlr3-/- mice. One of the following stimuli was added to triplicate wells of isolated macrophages and neutrophils: 2.5 mug/ml tri-palmitoyl-S-glyceryl cysteine (Pam3Cys; EMC Microcollections), 10 mug/ml poly(I:C) (GE Healthcare), 1 mug/ml LPS from Escherichia coli 0111:B4 (Sigma-Aldrich), or 2 muM CpG-ODN (Hycult biotechnology). Inflammatory chemokine generation by cultured macrophages and neutrophils was determined by ELISA or Bio-Plex at 24 and 5 h, respectively. In separate experiments, cultures of peritoneal macrophages cultures were co-cultured with necrotic neutrophils or apoptotic splenocytes in the ratio 0.5-1:1 macrophage, vimentin (1, 2, or 5 mug/ml; Cytoskeleton), or recombinant HMGB1 (10 mug/ml; R&D Systems). Necrotic neutrophils were generated from peritoneal neutrophils (73.4% were Gr1highCD11cneg) harvested at 16 h after i.p. thioglycollate injection and incubated at 55degreesC for 25 min, as previously described (46). Apoptotic splenocytes or neutrophils were generated by the addition of 1 muM staurosporine (Sigma Aldrich) for 6 h. In additional experiments, samples of 106 necrotic PMNs were treated with either 20 mug RNase (DNase and protease free; Roche) or 10 U/106 cells of Benzonase Nuclease (EMD) for 2 h at 37degreesC. After incubation, the necrotic cells were thoroughly washed and co-cultured with WT macrophages at a 1:1 ratio. Nucleic acid content in all necrotic PMN samples was determined with a RediPlate 96 RiboGreen RNA Quantitation kit (Invitrogen) according to the manufacturer's directions.
###end p 66
###begin title 67
Immunoneutralization of TLR3.
###end title 67
###begin p 68
###xml 503 508 <span type="species:ncbi:10090">mouse</span>
###xml 689 694 <span type="species:ncbi:10090">mouse</span>
Cultures of peritoneal macrophages were exposed to 150 mug/ml anti-TLR3 of control IgG antibody for 1.5 h. Subsequently, TLR2, 3, 4, and 9 ligands or necrotic neutrophils were added. In separate experiments, macrophages were preincubated with 10 muM chloroquine. 2 h later, all cells were washed and incubated with neutralizing anti-TLR3 or IgG antibodies for 90 min. After this incubation, the cultures were stimulated with poly(I:C). In in vivo experiments, control IgG or 1 mg anti-TLR3 antibody per mouse were injected i.p. at 2 h before and 6 h after total cecal ligation. 24 h later, cecums and serum were collected for analysis. In the CLP model, control IgG or anti-TLR3 (3 mg per mouse) were injected i.p. according to one of the following treatment regimens: (a) at 3 h before CLP surgery only; (b) 3 and 24 h after CLP surgery; and (c) at 6 and 24 h after CLP surgery. Survival was monitored for 54 h after the CLP surgery.
###end p 68
###begin title 69
Statistics.
###end title 69
###begin p 70
###xml 59 60 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 122 125 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 118 125 116 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
Data are expressed as mean +/- SEM. The Student's unpaired t test was used to evaluate the differences between WT and tlr3-/- groups. Survival studies were analyzed with the log-rank test. P </= 0.05 was considered significant.
###end p 70
###begin title 71
Online supplemental material.
###end title 71
###begin p 72
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tlr3<sup>&#8722;/&#8722;</sup></italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Fig. S1 A shows that the mRNA expression of TLR4 and 9 is increased in tlr3-/- mice after CLP. Fig. S1 B shows that the absence of TLR3 in neutrophils increased the responsiveness (i.e., chemokine production) of these cells to TLR4 (LPS). Fig. S2 shows that TLR3 activation increased the levels of AST, bilirubin, and LDH induced by septic peritonitis and gut ischemia. Fig. S3 shows that vimentin as well as HMGB1 proteins are not involved in the activation of TLR3 during acute inflammation. Fig. S4 shows that the polyclonal anti-TLR3 antibody used in the in vitro and in vivo studies attenuated the poly(I:C)-induced chemokine production and did not have any effect in the chemokine production induced by other TLR ligands. Fig. S5 shows that chemokine production mediated after TLR3 activation is not completely restricted by the endosomal acidification with chloroquine.
###end p 72
###begin title 73
Supplementary Material
###end title 73
###begin title 74
[Supplemental Material Index]
###end title 74
###begin p 75
We thank Ms. Robin Kunkel for graphic assistance, and Ms. Holly Evanoff, Mr. Aaron Berlin, Dr. Ron Allen, and Ms. Lisa Riggs for technical assistance.
###end p 75
###begin p 76
This work was supported in part by National Institutes of Health grants HL31237 and HL31963 (to S.L. Kunkel).
###end p 76
###begin p 77
The authors have declared that no competing financial interests exist.
###end p 77

